American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 273-280, February 2009

Association of the Q121 Variant of ENPP1 Gene With Decreased Kidney Function Among Patients With Type 2 Diabetes

  • Salvatore De Cosmo, MD

      Affiliations

    • Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • Corresponding Author InformationAddress correspondence to Salvatore De Cosmo, MD, Endocrinologia, Scientific Institute “Casa Sollievo della Sofferenza” V le Cappuccini 1, 71013 San Giovanni Rotondo (FG), Italy
    • ,
  • Antonio Minenna, MD

      Affiliations

    • Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • ,
  • Yuan-Yuan Zhang, PhD

      Affiliations

    • Joslin Diabetes Center, Boston, MA
    • ,
  • Robert Thompson, MD

      Affiliations

    • Joslin Diabetes Center, Boston, MA
    • ,
  • Giuseppe Miscio, PhD

      Affiliations

    • Research Unit of Diabetes and Endocrine Diseases, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • ,
  • Monica Vedovato, MD

      Affiliations

    • Chair of Metabolic Diseases, University of Padova, Padova, Italy
    • ,
  • Anna Rauseo, MD

      Affiliations

    • Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • ,
  • Alois Saller, MD

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Sandra Mastroianno, MD

      Affiliations

    • Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • ,
  • Fabio Pellegrini, MSc

      Affiliations

    • Research Unit of Diabetes and Endocrine Diseases, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    • ,
  • Roberto Trevisan, MD

      Affiliations

    • Unit of Diabetes, Ospedali Riuniti of Bergamo, Bergamo, Italy
    • ,
  • Paola Fioretto, MD

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Alessandro Doria, MD

      Affiliations

    • Joslin Diabetes Center, Boston, MA
    • ,
  • Vincenzo Trischitta, MD

      Affiliations

    • Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • Research Unit of Diabetes and Endocrine Diseases, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    • CSS-Mendel Institute, Sapienza University, Rome, Italy
    • Department of Clinical Sciences, Sapienza University, Rome, Italy
    • Corresponding Author InformationVincenzo Trischitta, MD, Istituto CSS-Mendel, V le R Margherita 261, 00198 Roma, Italy

Received 18 March 2008; accepted 29 July 2008. published online 28 October 2008.

Background

Insulin resistance has a role in diabetic kidney complications. The K121Q (lysine to glutamine substitution at amino acid 121, encoded by single-nucleotide polymorphism rs1044498) variant of the ectonucleotide pyrophosphatase/phosphodiesterase gene (ENPP1) has been associated with insulin resistance and related vascular complications in patients with type 2 diabetes (T2D) in many, although not all, studies. This study investigated whether the ENPP1 Q121 variant modulates the risk of decreased glomerular filtration rate (GFR) in patients with T2D.

Study Design

Cross-sectional study.

Setting & Participants

2 diabetes units from Italy (in Gargano and Padua) and 1 from the United States (Boston, MA) recruited a total of 1,392 patients with T2D.

Predictor

The ENPP1 Q121 variant.

Measurements

Estimated GFR from serum creatinine, urinary albumin excretion, blood pressure, hemoglobin A1c, triglycerides, total cholesterol, and high-density lipoprotein cholesterol.

Outcomes

Decreased GFRs (ie, estimated GFR <60 mL/min/1.73 m2).

Results

In the Gargano and Boston populations, according to the dominant model of inheritance, Q121 carriers (ie, individual with either KQ or QQ alleles) had an increased risk of decreased GFR: odds ratios (ORs) of 1.69 (95% confidence interval [CI], 1.1 to 2.6) and 1.50 (95% CI, 1.0 to 2.2), respectively. In the Padua set, the association was in the same direction, but did not reach formal statistical significance (OR, 1.77; 95% CI, 0.7 to 4.5). When the 3 studies were pooled, Q121 carriers showed an increased risk of decreased GFR (OR, 1.58; 95% CI, 1.2 to 2.1; P = 0.002). Also, pooled mean differences in absolute GFRs were different across genotype groups, with Q121 carriers showing lower GFRs compared with KK individuals (P = 0.04).

Limitations

P values not approaching a genome-wide level of significance.

Conclusions

Our data suggest that patients with T2D carrying the ENPP1 Q121 variant are at increased risk of decreased GFR.

Index Words: Gene polymorphism, insulin resistance, vascular diabetic complications, PC-1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2008.07.040 on October 28, 2008.

PII: S0272-6386(08)01298-5

doi:10.1053/j.ajkd.2008.07.040

Refers to erratum:

  • Errata

    American Journal of Kidney Diseases March 2010 (Vol. 55, Issue 3, Page 616)

American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 273-280, February 2009

Article Tools